Dealbreaker on MSN1h
Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult
Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered ...
MM&M5h
Backed by Recursion CEO, Altitude Lab venture aims to fill gap from NIH cuts
Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...
Pipe Dream6h
NIH funding cap prompts backlash from SUNY Chancellor King
Recent internal guidance restricting the National Institutes of Health’s spending could affect researchers across the country, including those at Binghamton University. On Jan. 22, ...